A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Extensive Stage Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- Status
- RECRUITING
- Phase
- PHASE1
Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Status
- RECRUITING
- Phase
- PHASE1
Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Efficacy Biomarker Investigation on Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC
- Status
- UNKNOWN
- Phase
- PHASE1
Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1